Invion

Subscribe to receive announcements and updates from Invion.

New investors

Home

Announcements

Updates

Lato

IVX_SkinCancerTrialStart.pdf

Invion completes lodgement of the trial application with the Human Research Ethics Committee (HREC).

Invion partners with Veracity Clinical Research to enrol patients for the skin cancer trial in Queensland with first patient recruitment expected in early 2024.

Adaptive trial design gives Invion greater flexibility to produce efficacy results on top of safety data in its Phase I/II non-melanoma skin cancer trial.

INVION ACHIEVES MILESTONE FOR PHASE I/II HUMAN CLINICAL TRIAL IN NON-MELANOMA SKIN CANCERS